
Vonomax20 mg
Popular Pharmaceuticals Ltd.

Tablet
Potassium competitive acid blocker
Voniza 20 mg is a potassium-competitive acid blocker (P-CAB) that suppresses gastric acid secretion by reversibly inhibiting the H⁺/K⁺-ATPase enzyme in parietal cells.
Due to its strong basic nature and prolonged retention in gastric parietal cells, Voniza 20 mg provides rapid, sustained, and potent acid suppression , helping protect the gastric mucosa and reduce upper gastrointestinal mucosal damage effectively.
| Condition | Dosage | Notes |
|---|---|---|
| The dose of Voniza 20 mg (Voniza 20 mg) varies depending on the condition being treated. It is administered orally once or twice daily , as prescribed by a physician | ||
| Gastric Ulcer Adult dose | 20 mg once daily Duration: Usually 8 weeks Duodenal Ulcer Adult dose: 20 mg once daily Duration: Usually 6 weeks Reflux Esophagitis Treatment dose: 20 mg once daily for 4 weeks If response is insufficient, treatment may be extended up to 8 weeks Maintenance Therapy Dose: 10 mg once daily May be increased to 20 mg once daily if needed Prevention of Ulcer Recurrence (Low-Dose Aspirin Use) Dose: 10 mg once daily Prevention of NSAID-Induced Ulcers Dose: 10 mg once daily Helicobacter pylori Eradication (Triple Therapy) Duration: 7 days, twice daily regimen Components per dose: Voniza 20 mg 20 mg Amoxicillin 750 mg Clarithromycin 200 mg (may be increased up to 400 mg twice daily if required) Second-Line H | pylori Eradication Therapy Duration: 7 days, twice daily regimen Components per dose: Voniza 20 mg 20 mg Amoxicillin 750 mg Metronidazole 250 mg |
Voniza 20 mg can be taken without regard to food or timing of food.
Voniza 20 mg is contraindicated in:
Like all medicines, Voniza 20 mg (Voniza 20 mg) may cause side effects, although not everyone experiences them.
Some patients may experience changes in liver function tests, including:
Most side effects are mild to moderate, but serious allergic reactions or liver problems require immediate medical attention and discontinuation of the medicine.
There is limited clinical experience with Voniza 20 mg (Voniza 20 mg) overdose. No specific pattern of severe toxicity has been established.
Patients suspected of overdose should be monitored closely and managed in a healthcare facility for appropriate supportive care.
Store below 30°C, in a cool and dry place. Keep away from light. Keep all the medicine out of the reach of children.
In elderly patients, hepatic and renal functions may be reduced, so Voniza 20 mg should be used with caution and careful clinical monitoring.
Store below 30°C, in a cool and dry place. Keep away from light. Keep all the medicine out of the reach of children.
What is Voniza 20 mg used for?
Vonoprazan is used for the treatment and prevention of acid-related stomach conditions, including gastric ulcer, duodenal ulcer, and reflux esophagitis . It also helps prevent ulcer recurrence in patients taking low-dose aspirin or NSAIDs . It is additionally used as part of Helicobacter pylori (H. pylori) eradication therapy , supporting recovery in conditions such as peptic ulcers, MALT lymphoma…
What is the dosage of Voniza 20 mg?
The dose of Vonoprazan (Vonoprazan) varies depending on the condition being treated. It is administered orally once or twice daily , as prescribed by a physician. Gastric Ulcer Adult dose: 20 mg once daily Duration: Usually 8 weeks Duodenal Ulcer Adult dose: 20 mg once daily Duration: Usually 6 weeks Reflux Esophagitis Treatment dose: 20 mg once daily for 4 weeks If response is insufficient, treat…
What are the side effects of Voniza 20 mg?
Like all medicines, Vonoprazan (Vonoprazan) may cause side effects, although not everyone experiences them. Common Side Effects Diarrhea Constipation Nausea Abdominal distension (bloating) Edema (swelling) Allergic Reactions Drug hypersensitivity reactions Skin rash, drug eruption, and urticaria (hives) Rare cases of anaphylactic shock Liver-Related Effects Some patients may experience changes in …
Who should not take Voniza 20 mg?
Vonoprazan is contraindicated in: Patients with hypersensitivity to Vonoprazan or to any excipient of the product. Patients receiving atazanavir sulphate, nelfinavir or rilpivirine hydrochloride
The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.